伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床特点分析

doi:10.3969/j.issn.1672-6731.2021.03.008

中国现代神经疾病杂志 ›› 2021, Vol. 21 ›› Issue (3): 170-176. doi: 10.3969/j.issn.1672-6731.2021.03.008

2 伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床特点分析

郑光耀¹, 包旭东², 卢琳², 冯铭³, 朱惠娟², 姚勇³, 王任直³

1. 261053 潍坊医学院临床医学院2019级;
2. 100730 中国医学科学院北京协和医学院北京协和医院内分泌科国家卫生健康委员会内分泌重点实验室协和转化医学中心;
3. 100730 中国医学科学院北京协和医学院神经外科

收稿日期:2021-03-19 出版日期:2021-03-25 发布日期:2021-04-02
通讯作者: 卢琳,Email:lulin88@sina.com
基金资助:
国家重点研发计划项目（项目编号：2016YFC0901500）；中国医学科学院医学与健康科技创新工程项目（项目编号：2017-I2M-1-011）；中国医学科学院中央级公益性科研院所基本科研业务费专项资助项目（项目编号：2017PT32020）；中国医学科学院中央级公益性科研院所基本科研业务费专项资助项目（项目编号：2018PT32001）

Clinical characteristics of adrenocorticotropic hormone-dependent Cushing's syndrome complicated with multiple endocrine neoplasia

ZHENG Guang-yao¹, BAO Xu-dong², LU Lin², FENG Ming³, ZHU Hui-juan², YAO Yong³, WANG Ren-zhi³

1 Grade 2019, Clinical Medical College of Weifang Medical University, Weifang 261053, Shandong, China;
2 Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Translational Medicine Center of Peking Union College Hospital, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China;
3 Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

Received:2021-03-19 Online:2021-03-25 Published:2021-04-02
Supported by:
This study was supported by the National Key Research and Developement Program of China (No. 2016YFC0901500), the Chinese Academy of Medical Sciences Innovation Fund for Medical Science (No. 2017-I2M-1-011), and Non-Profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2017PT32020, 2018PT32001).

摘要/Abstract

摘要：

目的总结伴多内分泌腺瘤病（MEN）的促肾上腺皮质激素（ACTH）依赖性库欣综合征的临床特点。方法纳入中国垂体疾病注册中心中国医学科学院北京协和医院分中心垂体瘤数据库1984年1月至2020年9月确诊的伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征患者18例，回顾分析其人口统计学、临床表现、实验室和影像学特征。结果 18例患者中库欣病13例，异位促肾上腺皮质激素综合征5例；MEN1型15例，MEN2型2例，MEN4型1例；临床表现为亚临床库欣综合征6例，显性库欣综合征12例；合并骨量减少或骨质疏松占18/18，泌尿系统结石占11/18；根据受累内分泌腺体，垂体促肾上腺皮质激素腺瘤占13/18，垂体催乳素（PRL）腺瘤占4/18，甲状旁腺功能亢进症占15/18，胰腺神经内分泌肿瘤占13/18，肾上腺腺瘤及增生占10/18。实验室检查，清晨血清皮质醇平均为（652.90±254.90）nmol/L，ACTH为（13.38±8.73）pmol/L，24 h尿游离皮质醇446.35（233.08，531.10）μg；2例血清PRL升高，13例甲状旁腺激素升高，11例钙离子升高。影像学检查，12例为垂体微腺瘤，3例为垂体大腺瘤；8例为肾上腺腺瘤，4例为肾上腺增粗，2例为肾上腺嗜铬细胞瘤，1例为腹主动脉旁副神经节瘤。基因检测，3例存在MEN1基因突变，分别为c.1183C > T、c.1579C > T和c.1174G > T突变。结论伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床罕见且表现复杂，主要表现为骨量减少和（或）骨质疏松；库欣综合征的最常见病因为垂体微腺瘤；MEN1型最多见，其他受累内分泌腺体主要为原发性甲状旁腺功能亢进症，其次为胰腺神经内分泌肿瘤。

关键词: 库欣综合征, 多发性内分泌腺瘤病, ACTH综合征, 异位, 诊断

Abstract:

Objective To summarize the clinical features of adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome (CS) with multiple endocrine neoplasia (MEN). Methods Based on the pituitary tumor database of Peking Union Medical College Hospital of China Pituitary Disease Register Network (CPDRN), 18 patients with ACTH-dependent CS complicated with MEN from January 1984 to September 2020 were collected. The clinical manifestations, involved other endocrine glands, laboratorial and imageological examinations were analyzed. Results Among 18 patients, 13 cases were Cushing's disease and 5 cases were ectopic ACTH syndrome (EAS); 15 cases were MEN1 type, 2 cases were MEN2 type and one case was MEN4 type. The clinical manifestations were subclinical CS in 6 cases and overt CS in 12 cases. All cases had osteopenia or osteoporosis. Urolithiasis accounted for 11/18 cases. Regarding the involved endocrine glands, pituitary ACTH adenoma accounted for 13/18 cases, prolactinoma accounted for 4/18 cases, hyperparathyroidism accounted for 15/18 cases, pancreatic neuroendocrine tumors accounted for 13/18 cases and adrenal adenomas and hyperplasia accounted for 10/18 cases. Laboratorial examinations showed the average morning serum cortisol was (652.90 ±254.90) nmol/L, the morning ACTH was (13.38 ±8.73) pmol/L and the 24 h urinary free cortisol was 446.35 (233.08, 531.10) μg. Serum prolactin was elevated in 2 cases, parathyroid hormone was elevated in 13 cases and serum calcium was elevated in 11 cases. In imageological examinations, there were pituitary microadenoma in 12 cases, pituitary macroadenoma in 3 cases, adrenal adenoma in 8 cases, thickened adrenal in 4 cases, adrenal pheochromocytoma in 2 cases, and paraganglioma in one case. Genetic test showed 3 cases had MEN1 gene mutation including c.1183C > T, c.1579C > T and c.1174G > T. Conclusions ACTH -dependent CS with MEN is a rare disease with complex manifestations. The most common symptom is osteopenia/osteoporosis. The most common cause of CS is pituitary microadenoma. MEN1 is the most common MEN type, and primary hyperparathyroidism is the most common type of affected endocrine glands, followed by pancreatic neuroendocrine tumors.

Key words: Cushing syndrome, Multiple endocrine neoplasia, ACTH syndrome, ectopic, Diagnosis

郑光耀, 包旭东, 卢琳, 冯铭, 朱惠娟, 姚勇, 王任直. 伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床特点分析[J]. 中国现代神经疾病杂志, 2021, 21(3): 170-176.

ZHENG Guang-yao, BAO Xu-dong, LU Lin, FENG Ming, ZHU Hui-juan, YAO Yong, WANG Ren-zhi. Clinical characteristics of adrenocorticotropic hormone-dependent Cushing's syndrome complicated with multiple endocrine neoplasia[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2021, 21(3): 170-176.

https://journal11.magtechjournal.com/cjcnn/CN/Y2021/V21/I3/170

参考文献

[1] Lindholm J, Juul S, Jørgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J. Incidence and late prognosis of cushing's syndrome:a population-based study[J]. J Clin Endocrinol Metab, 2001, 86:117-123.
[2] Colao A, Boscaro M, Ferone D, Casanueva FF. Managing Cushing's disease:the state of the art[J]. Endocrine, 2014, 47:9-20.
[3] Broder MS, Neary MP, Chang E, Cherepanov D, Ludlam WH. Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients < 65 years old in the United States[J]. Pituitary, 2015, 18:283-289.
[4] Yamazaki M, Suzuki S, Kosugi S, Okamoto T, Uchino S, Miya A, Imai T, Kaji H, Komoto I, Miura D, Yamada M, Uruno T, Horiuchi K, Sato A, Miyauchi A, Imamura M, Sakurai A; MEN Consortium of Japan. Delay in the diagnosis of multiple endocrine neoplasia type 1:typical symptoms are frequently overlooked[J]. Endocr J, 2012, 59:797-807.
[5] Castinetti F, Qi XP, Walz MK, Maia AL, Sansó G, Peczkowska M, Hasse-Lazar K, Links TP, Dvorakova S, Toledo RA, Mian C, Bugalho MJ, Wohllk N, Kollyukh O, Canu L, Loli P, Bergmann SR, Biarnes Costa J, Makay O, Patocs A, Pfeifer M, Shah NS, Cuny T, Brauckhoff M, Bausch B, von Dobschuetz E, Letizia C, Barczynski M, Alevizaki MK, Czetwertynska M, Ugurlu MU, Valk G, Plukker JT, Sartorato P, Siqueira DR, Barontini M, Szperl M, Jarzab B, Verbeek HH, Zelinka T, Vlcek P, Toledo SP, Coutinho FL, Mannelli M, Recasens M, Demarquet L, Petramala L, Yaremchuk S, Zabolotnyi D, Schiavi F, Opocher G, Racz K, Januszewicz A, Weryha G, Henry JF, Brue T, Conte-Devolx B, Eng C, Neumann HP. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2:an international retrospective population-based study[J]. Lancet Oncol, 2014, 15:648-655.
[6] Thakker RV. Multiple endocrine neoplasia type 1(MEN1) and type 4(MEN4)[J]. Mol Cell Endocrinol, 2014, 386:2-15.
[7] Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A; Endocrine Society. Treatment of Cushing's syndrome:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2015, 100:2807-2831.
[8] Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML; Endocrine Society. Clinical practice guidelines for multiple endocrine neoplasia type 1(MEN1)[J]. J Clin Endocrinol Metab, 2012, 97:2990-3011.
[9] Steffensen C, Bak AM, Rubeck KZ, Jørgensen JO. Epidemiology of Cushing's syndrome[J]. Neuroendocrinology, 2010, 92 Suppl 1:1-5.
[10] Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, O'Halloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV. Clinical studies of multiple endocrine neoplasia type 1(MEN1)[J]. QJM, 1996, 89:653-669.
[11] McDonnell JE, Gild ML, Clifton-Bligh RJ, Robinson BG. Multiple endocrine neoplasia:an update[J]. Intern Med J, 2019, 49:954-961.
[12] Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams textbook of endocrinology 14th edition[M]. Amsterdam:Elsevier, 2019:298-299.
[13] Simonds WF, Varghese S, Marx SJ, Nieman LK. Cushing's syndrome in multiple endocrine neoplasia type 1[J]. Clin Endocrinol (Oxf), 2012, 76:379-386.
[14] Chiodini I, Albani A, Ambrogio AG, Campo M, De Martino MC, Marcelli G, Morelli V, Zampetti B, Colao A, Pivonello R; ABC Group. Six controversial issues on subclinical Cushing's syndrome[J]. Endocrine, 2017, 56:262-266.
[15] Mazzuco TL, Bourdeau I, Lacroix A. Adrenal incidentalomas and subclinical Cushing's syndrome:diagnosis and treatment[J]. Curr Opin Endocrinol Diabetes Obes, 2009, 16:203-210.
[16] Tamada D, Kitamura T, Otsuki M, Oshino S, Saitoh Y, Shimomura I. Clinical significance of screening for subclinical Cushing's disease in patients with pituitary tumors[J]. Endocr J, 2016, 63:47-52.
[17] Teh BT, Zedenius J, Kytölä S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P. Thymic carcinoids in multiple endocrine neoplasia type 1[J]. Ann Surg, 1998, 228:99-105.
[18] Ferolla P, Falchetti A, Filosso P, Tomassetti P, Tamburrano G, Avenia N, Daddi G, Puma F, Ribacchi R, Santeusanio F, Angeletti G, Brandi ML. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome:the Italian series[J]. J Clin Endocrinol Metab, 2005, 90:2603-2609.
[19] Ghazi AA, Dezfooli AA, Mohamadi F, Yousefi SV, Amirbaigloo A, Ghazi S, Pourafkari M, Berney D, Ellard S, Grossman AB. Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1[J]. Endocr Pract, 2011, 17:e92-96.
[20] Norton JA, Krampitz G, Jensen RT. Multiple endocrine neoplasia:genetics and clinical management[J]. Surg Oncol Clin N Am, 2015, 24:795-832.
[21] Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia type 1 and 2[J]. Presse Med, 2018, 47:722-731.
[22] Buliman A, Tataranu LG, Paun DL, Mirica A, Dumitrache C. Cushing's disease:a multidisciplinary overview of the clinical features, diagnosis, and treatment[J]. J Med Life, 2016, 9:12-18.
[23] Valle Díaz de la Guardia F, Arrabal Martín M, Arrabal Polo MA, Quirosa Flores S, Miján Ortiz JL, Zuluaga Gómez A. Renal lithiasis in patients with primary hyperparathyroidism:evolution and treatment[J]. Arch Esp Urol, 2010, 63:32-40.

选择文件类型/文献管理软件名称

选择包含的内容

2 伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床特点分析

Clinical characteristics of adrenocorticotropic hormone-dependent Cushing's syndrome complicated with multiple endocrine neoplasia

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	冯珊珊. 基于危险因素的库欣病患者视力视野客观检查卫生经济学分析[J]. 中国现代神经疾病杂志, 2023, 23(7): 613-620.
[2]	贺电. 应重视实时震动诱导转化技术在克-雅病临床诊断中的应用[J]. 中国现代神经疾病杂志, 2023, 23(4): 271-274.
[3]	刘晓英. 癫痫发作与非癫痫性发作的鉴别诊断研究进展[J]. 中国现代神经疾病杂志, 2023, 23(2): 100-103.
[4]	李斐, 庄建华. 血管性眩晕和头晕临床诊断方法研究进展[J]. 中国现代神经疾病杂志, 2023, 23(2): 131-137.
[5]	王金涛, 王刚. 功能性神经系统疾病分类与诊断标准[J]. 中国现代神经疾病杂志, 2023, 23(2): 138-142.
[6]	朱以诚. 脑小血管病影像学诊断标准的更新解读[J]. 中国现代神经疾病杂志, 2023, 23(11): 955-958.
[7]	李智. 应关注颅内SMARCB1/INI-1缺陷型肿瘤的病理诊断与鉴别诊断：《罕见松果体区骨外黏液样软骨肉瘤》有感[J]. 中国现代神经疾病杂志, 2022, 22(12): 1068-1069.
[8]	杨学军, 陈宏, 李佳博, 孙翠云, 尹洪芳. 2021年世界卫生组织中枢神经系统肿瘤分类（第五版）整合及分层诊断解读[J]. 中国现代神经疾病杂志, 2021, 21(9): 764-768.
[9]	张文泰, 王任直, 冯铭. 库欣病患者术后即刻缓解影响因素分析[J]. 中国现代神经疾病杂志, 2021, 21(8): 665-669.
[10]	王佳伟, 曹阳月. 应重视无菌性脑膜炎及抗体阴性的自身免疫性脑炎的诊断[J]. 中国现代神经疾病杂志, 2021, 21(5): 335-338.
[11]	孙旭, 卢琳, 冯铭, 朱惠娟, 姚勇, 王任直. 库欣综合征伴围手术期肺栓塞临床特点分析[J]. 中国现代神经疾病杂志, 2021, 21(3): 177-184.
[12]	李海南, 李智. 局灶性皮质发育不良Ⅱ型与组织学相似疾病的病理学鉴别诊断要点[J]. 中国现代神经疾病杂志, 2020, 20(7): 655-658.
[13]	孙博文, 冯铭, 张家亮, 康军. 库欣病临床诊断研究进展[J]. 中国现代神经疾病杂志, 2020, 20(3): 162-165.
[14]	张成, 李欢. 面-肩-肱型肌营养不良症研究进展史[J]. 中国现代神经疾病杂志, 2019, 19(5): 299-311.
[15]	马原源, 俞萌, 李晓芳, 谢志颖, 李雪迎, 张哲, 袁云, 王朝霞. 血清肌酶谱在不同类型肌肉病中的鉴别诊断价值[J]. 中国现代神经疾病杂志, 2019, 19(5): 329-335.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 伴多内分泌腺瘤病的促肾上腺皮质激素依赖性库欣综合征临床特点分析

Clinical characteristics of adrenocorticotropic hormone-dependent Cushing's syndrome complicated with multiple endocrine neoplasia

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价